Unadjusted model | Final model (R2=0.102, p=0.009) | |||
β-coefficient (95% CI) | p-value | β-coefficient (95% CI) | p-value | |
Age yrs | 0.419 (0.025–0.814) | 0.037 | ||
BMI kg·m−2 | 1.015 (0.258–1.772) | 0.009 | 1.015 (0.258–1.772) | 0.009 |
Total SFA mg·L−1 | 0.003 (-0.023–0.028) | 0.840 | ||
Total MUFA mg·L−1 | 0.013 (-0.010–0.035) | 0.261 | ||
Total PUFA mg·L−1 | -0.008 (-0.029–0.013) | 0.456 | ||
ICS dose# μg·day−1 | 0.004 (-0.002–0.011) | 0.173 | ||
Use of ICS treatment yes/no | 8.508 (-3.147–20.163) | 0.150 |
BMI: body mass index; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; ICS: inhaled corticosteroid. #: beclomethasone equivalents.